scholarly article | Q13442814 |
P50 | author | Jennifer Elizabeth Below | Q56990564 |
Nancy J Cox | Q67954217 | ||
P2093 | author name string | Joseph R Testa | |
Ari Hirvonen | |||
Naomi K Fukagawa | |||
P2860 | cites work | Sex chromosomes, micronuclei and aging in women | Q45085978 |
Impact of interaction of polymorphic forms of p53 codon 72 and N-acetylation gene (NAT2) on the risk of lung cancer in the North Indian population. | Q45951167 | ||
Functional inactivation of NF2/merlin in human mesothelioma | Q46331478 | ||
Pleural malignant mesothelioma, genetic susceptibility and asbestos exposure | Q46580207 | ||
Intakes of vitamins A, C and E and folate and multivitamins and lung cancer: a pooled analysis of 8 prospective studies | Q46694352 | ||
A mouse model recapitulating molecular features of human mesothelioma | Q46706103 | ||
Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey | Q47322651 | ||
Patterns of c-fos and c-jun proto-oncogene expression, apoptosis, and proliferation in rat pleural mesothelial cells exposed to erionite or asbestos fibers | Q47680000 | ||
Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regression | Q47814346 | ||
Genetic predisposition to fiber carcinogenesis causes a mesothelioma epidemic in Turkey. | Q51199312 | ||
Significance of lymph node metastasis in patients with diffuse malignant peritoneal mesothelioma. | Q51798012 | ||
Adaptation of a commercial fluorescent in situ hybridization test to the diagnosis of malignant cells in effusions. | Q51820707 | ||
Nonrandom chromosome alterations in human malignant mesothelioma. | Q52829689 | ||
Frequent mutations of NF2 and allelic loss from chromosome band 22q12 in malignant mesothelioma: evidence for a two-hit mechanism of NF2 inactivation. | Q52832945 | ||
Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma. | Q53320850 | ||
Polymorphisms of glutathione-S-transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesothelioma. | Q53337015 | ||
Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. | Q53341193 | ||
Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 2: Prognosis and staging. | Q53389026 | ||
A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes. | Q55042984 | ||
[Massive exposure to asbestos and malignant mesothelioma, familial accumulation] | Q57071007 | ||
Neurofibromatosis 2 (NF2) and Malignant Mesothelioma in a Man with a Constitutional NF2 Missense Mutation | Q57266756 | ||
N-Acetyltransferase 1 in Colon and Rectal Cancer Cases from an Industrialized Area | Q57285518 | ||
Mesothelin-family proteins and diagnosis of mesothelioma | Q57297479 | ||
Risk of malignant pleural mesothelioma and polymorphisms in genes involved in the genome stability and xenobiotics metabolism | Q57610473 | ||
Familial malignant mesothelioma | Q57831198 | ||
[Familial malignant pleural mesothelioma. Report of 3 cases] | Q57910638 | ||
Clinical Significance of Serum Mesothelin in Patients with Mesothelioma and Lung Cancer | Q63254006 | ||
The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions | Q63547911 | ||
Vermiculite, respiratory disease and asbestos exposure in Libby, Montana: update of a cohort mortality study | Q23919146 | ||
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 | Q24322196 | ||
Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province | Q24516929 | ||
DNA methylation profiling of human chromosomes 6, 20 and 22 | Q24607522 | ||
Genetic susceptibility to distinct bladder cancer subphenotypes | Q24624419 | ||
p21-activated kinase links Rac/Cdc42 signaling to merlin | Q28207198 | ||
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers | Q28251857 | ||
A cell cycle regulator potentially involved in genesis of many tumor types | Q28251933 | ||
Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions | Q28262540 | ||
Polymorphisms in the putative micro-RNA-binding sites of mesothelin gene are associated with serum levels of mesothelin-related protein | Q28262557 | ||
Parametric and nonparametric linkage analysis: a unified multipoint approach | Q28762162 | ||
BTS statement on malignant mesothelioma in the UK, 2007. | Q30478994 | ||
Familial mesothelioma. Details of 17 cases with histopathologic findings and mineral analysis | Q33389946 | ||
Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas | Q33390251 | ||
Cytogenetics and fluorescence in situ hybridization as adjuncts to cytology in the diagnosis of malignant mesothelioma | Q33470425 | ||
Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma | Q33680576 | ||
The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression | Q33707642 | ||
High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas | Q33738528 | ||
Malignant mesothelioma in subjects with Marfan's syndrome and Ehlers-Danlos syndrome: only an apparent association? | Q33895748 | ||
The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure | Q33927422 | ||
Genomic events associated with progression of pleural malignant mesothelioma | Q34103109 | ||
Accelerated telomere shortening in the human inactive X chromosome | Q34146328 | ||
SV40 and human tumours: myth, association or causality? | Q34161997 | ||
Latent period for malignant mesothelioma of occupational origin | Q34298119 | ||
Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial | Q34405938 | ||
Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients | Q34485292 | ||
Prospective study of mesothelioma mortality in Turkish villages with exposure to fibrous zeolite | Q34502204 | ||
The pathogenesis of mesothelioma | Q34522971 | ||
Non-asbestos related diffuse malignant mesothelioma. | Q34634011 | ||
History of the use and toxicity of thorotrast | Q34693119 | ||
Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas | Q34759870 | ||
Fibrous zeolite (erionite)-related diseases in Turkey | Q34779609 | ||
The relationship between simian virus 40 and mesothelioma. | Q34783984 | ||
Cruciferous vegetable consumption and lung cancer risk: a systematic review | Q34915650 | ||
Sex disparities in cancer incidence by period and age. | Q34964129 | ||
CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis | Q34977971 | ||
Anticancer effects of phytosterols | Q34984594 | ||
Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up | Q35183061 | ||
Erionite bodies and fibres in bronchoalveolar lavage fluid (BALF) of residents from Tuzköy, Cappadocia, Turkey | Q35493920 | ||
Analysis of loss of inactive X chromosomes in interphase cells. | Q35882181 | ||
Erionite exposure and mesotheliomas in rats | Q35992217 | ||
Dietary intake and the risk of malignant mesothelioma | Q36134802 | ||
Implications of P16/CDKN2A deletion in pleural mesotheliomas | Q36160252 | ||
Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma | Q36225781 | ||
An outbreak of pleural mesothelioma and chronic fibrosing pleurisy in the village of Karain/Urgüp in Anatolia | Q36451344 | ||
Cytogenetic and molecular genetic changes in malignant mesothelioma. | Q36590884 | ||
Zeolite bodies in human lungs from Turkey. | Q36595524 | ||
Medical surveillance of workers previously exposed to asbestos | Q36607139 | ||
Mesothelioma in blood related subjects: report of 11 clusters among 1954 Italy cases and review of the literature | Q36779596 | ||
Complex disease, gender and epigenetics | Q36793656 | ||
Diet and cancer: facts and controversies | Q36809099 | ||
Biomarkers for mesothelioma. | Q36833924 | ||
Genetic susceptibility to malignant mesothelioma and exposure to asbestos: the influence of the familial factor. | Q36955203 | ||
A review of carcinogenicity studies of asbestos and non-asbestos tremolite and other amphiboles | Q37002104 | ||
Activated TNF-alpha/NF-kappaB signaling via down-regulation of Fas-associated factor 1 in asbestos-induced mesotheliomas from Arf knockout mice | Q37101238 | ||
Nutrition in early life, and risk of cancer and metabolic disease: alternative endings in an epigenetic tale? | Q37112678 | ||
Epigenetic interplay between histone modifications and DNA methylation in gene silencing | Q37137074 | ||
Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases | Q37141613 | ||
Dietary intake of selected flavonols, flavones, and flavonoid-rich foods and risk of cancer in middle-aged and older women | Q37155227 | ||
Epigenetic drivers and genetic passengers on the road to cancer. | Q37159924 | ||
Carotenoids and the risk of developing lung cancer: a systematic review | Q37238593 | ||
Garlic intake and cancer risk: an analysis using the Food and Drug Administration's evidence-based review system for the scientific evaluation of health claims | Q37341272 | ||
Chromosomal deletion in patients with malignant pleural mesothelioma | Q37433297 | ||
Ionizing radiation: a risk factor for mesothelioma | Q37483623 | ||
Polymorphisms in DNA repair genes as risk factors for asbestos-related malignant mesothelioma in a general population study. | Q38314777 | ||
A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type | Q38425438 | ||
Survival of pleural malignant mesothelioma in Italy: a population-based study | Q38454393 | ||
N-acetyltransferase-2 and medical history in bladder cancer cases with a suspected occupational disease (BK 1301) in Germany | Q38455624 | ||
An epidemiological study in an Anatolian village in Turkey environmentally exposed to tremolite asbestos | Q38507794 | ||
The micronucleus test | Q39325239 | ||
Contribution of the Environment to Cancer Incidence: An Epidemiologic Exercise | Q39619319 | ||
Case-control study of diet and mesothelioma in Louisiana | Q39710093 | ||
Familial mesothelioma: review and family study | Q39855923 | ||
A novel mechanism of late gene silencing drives SV40 transformation of human mesothelial cells | Q39916361 | ||
A conditional mouse model for malignant mesothelioma | Q40004544 | ||
Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32. | Q40176023 | ||
Re-expression of the tumor suppressor NF2/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK. | Q40284714 | ||
Environmental mesothelioma in Turkey | Q40632252 | ||
Diffuse malignant mesothelioma. Prospective evaluation of 69 patients | Q40844231 | ||
Analysis of current trends in United States mesothelioma incidence | Q40906672 | ||
Genetic factors in the aetiology of malignant mesothelioma | Q40934505 | ||
Parental cancer and genetic predisposition in malignant pleural mesothelioma: a case-control study | Q40971434 | ||
Recurring loss involving chromosomes 1, 3, and 22 in malignant mesothelioma: possible sites of tumor suppressor genes. | Q41218472 | ||
Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients | Q41226875 | ||
Survival patterns for malignant mesothelioma: the SEER experience | Q41435451 | ||
Malignant mesothelioma and radiological chest abnormalities in two villages in Central Turkey. An epidemiological and environmental investigation | Q41531811 | ||
Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience | Q41688263 | ||
Adenovirus-mediated p14(ARF) gene transfer in human mesothelioma cells | Q41731114 | ||
Lung diseases due to environmental exposures to erionite and asbestos in Turkey | Q42040778 | ||
North american erionite-associated mesothelioma with pleural plaques and pulmonary fibrosis: a case report | Q42081037 | ||
Pluripotential nature of mesotheliomata induced by inhalation of erionite in rats. | Q42615537 | ||
Occupation and cancer - follow-up of 15 million people in five Nordic countries | Q43238712 | ||
Epidemiological and environmental evidence of the health effects of exposure to erionite fibres: a four-year study in the Cappadocian region of Turkey | Q44002675 | ||
Hemizygosity of Nf2 is associated with increased susceptibility to asbestos-induced peritoneal tumours | Q44475274 | ||
Metabolic genotypes as modulators of asbestos-related pleural malignant mesothelioma risk: a comparison of Finnish and Italian populations | Q44557750 | ||
Factors influencing long-term survival in mesothelioma patients--results of the German mesothelioma register | Q44610633 | ||
Nonrandom chromosomal abnormalities in malignant pleural mesothelioma | Q44645508 | ||
Familial mesothelioma: a report of two families | Q45073175 | ||
The Protective Effect of the Mediterranean Diet on Lung Cancer | Q63560163 | ||
Pleural mesotheliomas in Sprague-Dawley rats by erionite: first experimental evidence | Q67233780 | ||
Familial mesothelioma after intense asbestos exposure at home | Q67343632 | ||
Mesothelioma in rats following intrapleural injection of chrysotile and phosphorylated chrysotile (chrysophosphate) | Q67487183 | ||
Malignant mesothelioma of the pleura. A prospective therapeutic study of 132 patients from 1981-1985 | Q68003877 | ||
Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985 | Q68250517 | ||
Cytogenetic analysis of malignant mesothelioma | Q68824708 | ||
Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study | Q68929587 | ||
Asbestos-contaminated nappies and familial mesothelioma | Q69368739 | ||
Chromosome changes in malignant mesothelioma | Q69994410 | ||
The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial | Q70234542 | ||
Endemic pleural disease associated with exposure to mixed fibrous dust in Turkey | Q70322932 | ||
Familial clustering of malignant mesothelioma | Q71208368 | ||
Malignant mesothelioma in two pairs of siblings: is there a hereditary predisposing factor? | Q71352818 | ||
Inherited GSTM1 and NAT2 defects as concurrent risk modifiers in asbestos-related human malignant mesothelioma | Q71862667 | ||
Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders | Q71878642 | ||
Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer | Q72610940 | ||
p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma | Q72710443 | ||
Prognostic factors and survival in malignant pleural mesothelioma | Q72716597 | ||
Prognostic factors of malignant mesothelioma of the pleura | Q72800457 | ||
Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma | Q72910658 | ||
Environmental fibrous zeolite (erionite) exposure and malignant tumors other than mesothelioma | Q73496989 | ||
Genetic susceptibility and familial malignant mesothelioma | Q74023101 | ||
Neurofibromatosis 2 and malignant mesothelioma | Q74506353 | ||
Familial pleural malignant mesothelioma: clustering in three sisters and one cousin | Q77342056 | ||
Dietary zinc, copper and selenium, and risk of lung cancer | Q79387878 | ||
Erionite and asbestos differently cause transformation of human mesothelial cells | Q79926059 | ||
Identification of a mesothelioma phenotype | Q80140255 | ||
Malignant pleural mesothelioma | Q80200957 | ||
MN/CA9: a potential gene marker for detection of malignant cells in effusions | Q80402811 | ||
Asbestos exposure, pleural mesothelioma, and serum osteopontin levels | Q81344951 | ||
Environmental exposure to Libby Asbestos and mesotheliomas | Q81692989 | ||
Characterization of a complex chromosome aberration in two cases of peritoneal mesothelioma arising primarily in the hernial sac | Q83978352 | ||
Association of NAT2 gene polymorphisms with susceptibility to esophageal and gastric cancers in the Kashmir Valley | Q84574223 | ||
P433 | issue | 1-4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 246-66 | |
P577 | publication date | 2011-01-01 | |
P1433 | published in | Journal of Toxicology and Environmental Health Part B: Critical Reviews | Q15724534 |
P1476 | title | Factors that impact susceptibility to fiber-induced health effects | |
P478 | volume | 14 |
Q47266569 | A genetic variant of NLRP1 gene is associated with asbestos body burden in patients with malignant pleural mesothelioma |
Q51214933 | Characterization of a French series of female cases of mesothelioma. |
Q38972707 | Five years update on relationships between malignant pleural mesothelioma and exposure to asbestos and other elongated mineral particles |
Q34692085 | Genetic variants associated with increased risk of malignant pleural mesothelioma: a genome-wide association study. |
Q23918083 | Meeting report: mode(s) of action of asbestos and related mineral fibers |
Q38107102 | Molecular pathogenesis of malignant mesothelioma |
Q29248572 | Mortality from asbestos-associated disease in Libby, Montana 1979–2011 |
Q26859274 | New insights into understanding the mechanisms, pathogenesis, and management of malignant mesotheliomas |
Q37951552 | Potential health hazards associated with exposures to asbestos-containing drywall accessory products: A state-of-the-science assessment |
Q38125794 | The role of genotoxicity in asbestos-induced mesothelioma: an explanation for the differences in carcinogenic potential among fiber types. |
Search more.